ABSI
Absci Corp
NASDAQ: ABSI · HEALTHCARE · BIOTECHNOLOGY
$4.71
-3.09% today
Updated 2026-04-29
Market cap
$732.16M
P/E ratio
—
P/S ratio
261.48x
EPS (TTM)
$-0.84
Dividend yield
—
52W range
$2 – $5
Volume
4.1M
Absci Corp (ABSI) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-5,453.00%
ROE
-62.50%
ROA
-36.30%
Debt/equity
0.03x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $2.06M | $-6.58M | 100.00% | -304.13% | -319.61% |
| 2020 | $4.78M | $-14.35M | -139.50% | -278.26% | -300.27% |
| 2021 | $4.78M | $-100.96M | -832.37% | -1,573.36% | -2,111.25% |
| 2022 | $5.75M | $-104.90M | -925.02% | -1,857.49% | -1,825.37% |
| 2023 | $5.72M | $-110.57M | -731.88% | -2,020.20% | -1,933.65% |
| 2024 | $4.53M | $-103.11M | -1,277.57% | -2,401.59% | -2,274.06% |
| 2025 | $2.80M | $-115.18M | -319.36% | -4,454.21% | -4,113.68% |